Suchergebnisse - "Patel, Bharat"

PubPharm (313)

41

Infection and transmission of SARS-CoV-2 in London care homes reporting no cases or outbreaks of COVID-19 : Prospective observational cohort study, England 2020

enthalten in: The Lancet regional health. Europe | 2021

von Jeffery-Smith, A. | Dun-Campbell, K. | Janarthanan, R. | +26

42

SYSTEM FOR TARGETED APPLICATION OF TOPICAL AGENTS TO AN ISOLATED BODY PART

enthalten in: Europäisches Patentamt | 2021

von ALARY MARC | LIU JAN-JOO | LUNDE ERIK | +2

43

활성제의 전달을 위한 3차원 미세유체학 장치

enthalten in: Europäisches Patentamt | 2021

von ALARY MARC | HOPSON PEYTON | LIU JAN JOO | +2

44

MULTI-FUNCTIONAL PERSONALIZED PATCH WITH THERAPEUTIC PROPERTIES

enthalten in: Europäisches Patentamt | 2021

von ALARY MARC | LIU JAN-JOO | PATEL BHARAT

45

MULTI-FUNCTIONAL PERSONALIZED PATCH WITH THERAPEUTIC PROPERTIES

enthalten in: Europäisches Patentamt | 2021

von ALARY MARC | LIU JAN-JOO | PATEL BHARAT

46

Ventriculoperitoneal Shunt Malfunction, a Rare Cause of Paraplegia after Kyphosis Correction : A Case Report and Literature Review

enthalten in: Spine | 2021

von Patel, B. | Bapat, M.

47

Screening for Candida auris in patients admitted to eight intensive care units in England, 2017 to 2018

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2021

von Sharp, A. | Muller-Pebody, B. | Charlett, A. | +22

48

Cross-sectional observational study of epidemiology of COVID-19 and clinical outcomes of hospitalised patients in North West London during March and April 2020

enthalten in: BMJ open | 2021

von Gopal Rao, G. | Allen, A. | Papineni, P. | +38

49

High prevalence of SARS-CoV-2 antibodies in care homes affected by COVID-19; prospective cohort study, England

enthalten in: bioRxiv.org | 2021

von Ladhani, S. | Jeffery-Smith, A. | Patel, M. | +25

50

THREE-DIMENSIONAL MICROFLUIDICS DEVICES FOR THE DELIVERY OF ACTIVES

enthalten in: Europäisches Patentamt | 2021

von ALARY MARC | HOPSON PEYTON | LIU JAN-JOO | +2